Search - tctmd.com

Displaying 361 - 380 of 1143

Sort: Relevancy | Date

Presentation TCT 2018

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

Presenter: Akihide Konishi

September 22, 2018

Presentation TCT 2018

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Presenter: Alfredo Trento

September 22, 2018

Presentation TCT 2018

Evolving PFO Closure Practice and Challenges in the U.S.

Presenter: Teiji Akagi, John D. Carroll, Richard Smalling

September 22, 2018

Presentation TCT 2018

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Presenter: Michael J. Mack

September 22, 2018

Presentation TCT 2018

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Presenter: Marek Grygier

September 22, 2018

Presentation TCT 2018

Evolving PFO Closure Practice and Challenges in Europe

Presenter: Teiji Akagi, John D. Carroll, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Presenter: Patrick T. O'Gara

September 22, 2018

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

Presentation TCT 2018

Evolving PFO Closure Practice and Challenges in Asia

Presenter: Teiji Akagi, John D. Carroll

September 22, 2018

Presentation TCT 2018

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Presenter: Martin B. Leon

September 22, 2018

Presentation TCT 2018

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Presenter: Joseph E. Bavaria

September 22, 2018

Presentation TCT 2018

Evolving PFO Closure Practice and Challenges in Canada

Presenter: Teiji Akagi, John D. Carroll, Eric Horlick

September 22, 2018

Presentation TCT 2018

Opinion Concerns of TAVR Access for Underserved Populations

Presenter: Aaron Horne, Jr.

September 22, 2018

Presentation TCT 2018

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

Presenter: Teiji Akagi, John D. Carroll, Konstantinos Dean Boudoulas

September 22, 2018

Presentation TCT 2018

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Presenter: Mark J. Russo

September 22, 2018

Presentation TCT 2018

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

Presenter: Carl L. Tommaso

September 22, 2018

Presentation TCT 2018

Case #1: From Indonesia: Catheter Induced Dissection With Acute Vessel Closure, Aortic Dissection, and Perforation

Presenter: Vinay K. Bahl, Huay Cheem Tan, Jun-Jack Cheng, Kenneth Chin, Jeehoon Kang, Sreenivas Arramraju Kumar, Linda Lison, Fazila T. Malik

September 22, 2018

Presentation TCT 2018

Case #1: Should This PFO Be Closed in a Patient With A Cryptogenic Stroke?

Presenter: Teiji Akagi, John D. Carroll, Lee N. Benson, Stefan C. Bertog, Clifford J. Kavinsky, David W.M. Muller, Francesco Pelliccia, A.J. Conrad C. Smith

September 22, 2018

Presentation TCT 2018

Take-Home Messages: What Did We Learn From These Cases?

Presenter: Massimo Napodano, Bernard Prendergast

September 22, 2018

Advertisement

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Evolving PFO Closure Practice and Challenges in the U.S.

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Evolving PFO Closure Practice and Challenges in Europe

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Evolving PFO Closure Practice and Challenges in Asia

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Evolving PFO Closure Practice and Challenges in Canada

Opinion Concerns of TAVR Access for Underserved Populations

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

Case #1: From Indonesia: Catheter Induced Dissection With Acute Vessel Closure, Aortic Dissection, and Perforation

Case #1: Should This PFO Be Closed in a Patient With A Cryptogenic Stroke?

Take-Home Messages: What Did We Learn From These Cases?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content